Home > News > avVaa World Health Care Products Launches New Clinical Trial Studies
December 26th, 2006
avVaa World Health Care Products Launches New Clinical Trial Studies
Abstract:
Alden continued, "The results of a recent German trial comparing NEUROSKIN Forte (Psoriasis) and NEUROSKIN Mild will be published as part of that ad campaign and have already been presented at the New Jersey Technology Council conference on nanotechnology that we attended this past summer."
Source:
yahoo.com
Bookmark:
Announcements
Aspen Aerogels Announces $22.5 Million Private Placement May 18th, 2013
NanoInk, Inc. Assets To Be Sold May 18th, 2013
NIA Public Briefing: Nanotechnology and the Council of Europe May 17th, 2013
Scientists capture first direct proof of Hofstadter butterfly effect May 17th, 2013
Human Interest/Art
Oh, Christmas tree, oh Christmas tree: A nano end for Christmas tree needles January 2nd, 2013
INIC Inks MoU to Apply Nanotechnology in Iran's Carpet Industry December 18th, 2012
IBN Welcomes Its First 9-Year-Old ‘Scientist’: IBN and Make-A-Wish Foundation Singapore Make Kidney Patient’s Dream Come True December 10th, 2012
The music of the silks: Researchers synthesize a new kind of silk fiber — and find that music can help fine-tune the material’s properties November 28th, 2012